AstraZeneca: Yingfeifan combined chemotherapy approved in China as the first immunotherapy regimen for advanced biliary cancer patients
因醉鞭名马幌
发表于 2023-11-14 17:04:48
249
0
0
On November 14th, AstraZeneca announced that Infineon&Co; Reg; (English trade name: IMFINZI®, common name: Duvalizumab) has officially obtained approval from the National Drug Administration on November 7th for the combination of gemcitabine and cisplatin for first-line treatment of locally advanced or metastatic biliary tract cancer (BTC) in adult patients. This plan is the first approved immunotherapy plan for biliary tract cancer in China.
CandyLake.com is an information publishing platform and only provides information storage space services.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
Disclaimer: The views expressed in this article are those of the author only, this article does not represent the position of CandyLake.com, and does not constitute advice, please treat with caution.
转播
You may like
- Xiaopeng Motors: The first product in the MONA series named Xiaopeng M03
- Before the United States! What is the safety and efficacy of the world's first weekly insulin injection approved in China
- The world's first! French regulatory authorities sue NVIDIA
- Alibaba launches the first AI picture book tool in China to care for children with autism
- JD Group and Hailan Group have reached a strategic cooperation and will open the first JD Aolai offline store
- NIO's first fourth substitution power station in Beijing officially goes online
- New breakthrough in AI chips! SK Hynix, the world's first to achieve mass production of 12 layer HBM3E products, saw its stock price surge by nearly 9%
- The first new force in car manufacturing! Ideal car's one millionth complete vehicle rolled off the production line
- Mingchuang Youpin Ye Guofu: Retail industry should not compromise on prices. Going abroad should first go to Southeast Asia and then to Europe and America
- Is OpenAI's first AI assistant product for the 'next major breakthrough' or will it be released in January next year to revolutionize human-computer interaction?
-
11월 14일, 세계예선 아시아지역 제3단계 C조 제5라운드, 중국남자축구는 바레인남자축구와 원정경기를 가졌다.축구 국가대표팀은 바레인을 1-0으로 꺾고 예선 2연승을 거두었다. 특히 이번 경기 국내 유일한 중계 ...- 我是来围观的逊
- 어제 15:05
- Up
- Down
- Reply
- Favorite
-
계면신문기자 장우발 4분기의 영업수입이 하락한후 텐센트음악은 다시 성장으로 돌아왔다. 11월 12일, 텐센트음악은 최신 재보를 발표했다.2024년 9월 30일까지 이 회사의 3분기 총수입은 70억 2천만 위안으로 전년 ...- 勇敢的树袋熊1
- 3 일전
- Up
- Down
- Reply
- Favorite
-
본사소식 (기자 원전새): 11월 14일, 다다그룹 (나스닥코드: DADA) 은 2024년 3분기 실적보고를 발표했다. 수치가 보여준데 따르면 고품질발전전략에 지속적으로 전념하고 사용자체험을 끊임없이 최적화하며 공급을 ...- 家养宠物繁殖
- 그저께 15:21
- Up
- Down
- Reply
- Favorite
-
11월 12일 소식에 따르면 소식통에 따르면 아마존은 무료스트리밍서비스 Freevee를 페쇄하고 일부 종업원과 프로를 구독서비스 Prime Video로 이전할 계획이다. 올해 초 아마존이 내놓은 몇 편의 대형 드라마의 효 ...- 度素告
- 3 일전
- Up
- Down
- Reply
- Favorite
